Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ICON plc (ICLR)

  • Business News
  • Dec. 02, 2025, 12:15 UTC
  • 13
  • 1 comments

ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

Market reaction Comment Full text

Nkarta Inc (NKTX)

  • Business News
  • Dec. 02, 2025, 12:09 UTC
  • 10
  • 1 comments

Nkarta to Participate in Evercore Healthcare Conference

Market reaction Comment Full text

Owlet Inc. (OWLT)

  • Business News
  • Dec. 02, 2025, 12:05 UTC
  • 9
  • 1 comments

Owlet Baby Care Inc. - Owlet Earns Spot on FastCompany’s 2025 Brands That Matter List

Market reaction Comment Full text

Owlet Inc. (OWLT)

  • Business News
  • Dec. 02, 2025, 12:05 UTC
  • 9
  • 1 comments

Owlet Earns Spot on Fast Company’s 2025 Brands That Matter List

Market reaction Comment Full text

Ovid Therapeutics Inc (OVID)

  • Business News
  • Dec. 02, 2025, 12:02 UTC
  • 9
  • 1 comments

Ovid Therapeutics Inc. - Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer

Market reaction Comment Full text

Ventyx Biosciences (VTYX)

  • Business News
  • Dec. 02, 2025, 12:02 UTC
  • 9
  • 1 comments

Ventyx Provides Clinical and Corporate Updates

Market reaction Comment Full text

Fennec Pharmaceuticals Inc (FENC)

  • Business News
  • Dec. 02, 2025, 12:01 UTC
  • 9
  • 1 comments

Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing Loss

Market reaction Comment Full text

Jasper Therapeutics Inc. (JSPRW)

  • Business News
  • Dec. 02, 2025, 12:00 UTC
  • 9
  • 1 comments

Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma and Findings from BEACON Study Internal Investigation

Market reaction Comment Full text

Ovid Therapeutics Inc (OVID)

  • Business News
  • Dec. 02, 2025, 12:00 UTC
  • 10
  • 1 comments

Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer

Market reaction Comment Full text

CervoMed Inc (CRVO)

  • Business News
  • Dec. 02, 2025, 12:00 UTC
  • 9
  • 1 comments

CervoMed Presents New Plasma Biomarker Data That Indicates Neflamapimod Broadly Improves Neuroinflammation and Neurodegeneration in Dementia with Lewy Bodies (DLB)

Market reaction Comment Full text
  • Previous
  • 459
  • 460
  • 461
  • 462
  • 463
  • Next

Search

News categories

  • Technical Exchange News(10936)
  • Event(2357)
  • SEC News(191243)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125093)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin